Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective study

Several new, pangenotypic direct-acting antiviral agents (DAAs) have been approved, may reduce the need for genotyping to guide therapy decisions for patients with chronic hepatitis C (CHC). This study aimed to investigate the efficacy and safety of Sofosbuvir (SOF)-based pangenotypic DAAs therapy f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Li, Juan, Wu, Dong-Bo, Jiang, Wei, Chen, Xue-Bin, Xiao, Gui-Bao, Wang, Yong-Hong, Wang, Meng-Lan, Tao, Ya-Chao, Chen, En-Qiang
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
4500
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581131/
https://ncbi.nlm.nih.gov/pubmed/33120769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000022726
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados